Position in CING
as of Mar 31, 2026
· filed May 14, 2026
Position Value
$171
+$129 QoQ
Shares Held
27,528
+155.6% QoQ
Ownership
0.207%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Jun 2024
4 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in CING Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026Virtu Financial LLC holds $39,779 across 141 Biotechnology names. CING ranks #62 (0.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
7,634 | $3,409 | |
| 2 | BMRN |
Biomarin Pharmaceutical Inc
|
38,479 | $2,174 | |
| 3 | IBRX |
ImmunityBio, Inc.
|
262,298 | $2,012 | |
| 4 | ANAB |
Anaptysbio, Inc
|
33,323 | $1,848 | |
| 5 | ABVX |
Abivax S.A.
|
9,551 | $1,063 | |
| 6 | OCGN |
Ocugen, Inc.
|
582,052 | $1,054 | |
| 7 | IOVA |
Iovance Biotherapeutics, Inc.
|
285,829 | $1,003 | |
| 8 | PVLA |
Palvella Therapeutics, Inc.
|
7,726 | $963 |
All Filings in CING
Export CSV
4 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $171 | 27,528 | Shares | Defined | 2026-05-14 | |
| 2025-09-30 | $42 | 10,772 | Shares | Defined | 2025-11-14 | |
| 2025-06-30 | $54 | 13,351 | Shares | Defined | 2025-08-12 | |
| 2024-06-30 | $6 | 20,170 | Shares | Defined | 2024-08-09 | |
| No filing history on record for this holder in this stock. | ||||||